Arimidex (Anastrozole)

What Is Arimidex?

Arimidex is the brand name for anastrozole, an oral prescription medicine belonging to a class of drugs called aromatase inhibitors. It is primarily used to treat certain types of hormone-sensitive breast cancer in postmenopausal women.

Anastrozole works by reducing the production of estrogen in the body. Some breast cancer cells depend on estrogen signals to grow. By lowering estrogen levels, anastrozole may help slow the growth of hormone receptor-positive breast cancer or reduce the risk of cancer returning after initial treatment.

In Canada, Arimidex is listed as a prescription medicine containing 1 mg of anastrozole in tablet form. Health Canada records Arimidex as a marketed human prescription product.

Arimidex is not a vitamin, natural health product, bodybuilding supplement or general-purpose hormone-balancing product. It should only be used for an appropriate medical reason determined by a qualified healthcare professional.

Legal access requires a valid prescription and dispensing through an appropriate pharmacy. A website offering anastrozole without a prescription may be selling an unauthorized, counterfeit or improperly stored product. Consumers should verify medicine details through Health Canada's Drug Product Database or consult a Canadian pharmacist.

What Is Arimidex Used For?

Arimidex is used for selected cases of hormone-sensitive breast cancer, primarily in postmenopausal women. Canadian product information identifies anastrozole as a treatment for hormone receptor-positive early breast cancer and advanced breast cancer in appropriate postmenopausal patients.

Depending on the clinical situation, anastrozole may be used as adjuvant treatment after surgery for hormone receptor-positive early breast cancer, as an initial treatment for locally advanced or metastatic hormone-sensitive breast cancer, or after previous tamoxifen treatment when the cancer has progressed.

The treatment plan depends on cancer stage, hormone receptor status, previous therapies, menopause status, general health, bone health and patient preferences. Anastrozole does not replace surgery, radiation, chemotherapy, targeted therapy or other treatments when those are recommended.

People sometimes search for Arimidex to reduce estrogen-related effects associated with anabolic steroids or testosterone use. This is not a safe reason to self-medicate. Excessively lowering estrogen can cause joint symptoms, sexual problems, mood changes, adverse cholesterol changes and bone loss.

Dosage and Administration

The correct Arimidex dose depends on the approved indication, treatment plan and individual patient. For many approved breast-cancer indications, Canadian product information describes anastrozole as a 1 mg oral tablet taken once daily. Patients should follow the exact prescription label and never change the dose without speaking with their oncologist or pharmacist.

Take the tablet at approximately the same time each day. It may generally be taken with or without food and should be swallowed with water unless a pharmacist provides different instructions. Do not stop treatment, share tablets or use medicine obtained from an unauthorized website.

If a dose is missed, follow the instructions provided by the pharmacist or oncology team. Do not take extra tablets to compensate unless a healthcare professional specifically instructs you to do so.

Treatment duration varies. Some patients receive Arimidex for a defined period after surgery, while others use it for advanced disease or as part of a sequence with another hormonal therapy. Long-term estrogen suppression can affect bone density, cholesterol, cardiovascular health and quality of life.

Healthcare professionals may monitor cancer response, bone mineral density, bone and joint symptoms, cholesterol, cardiovascular risk, liver function when appropriate, reproductive status and other medicines.

How Does Anastrozole Affect the Body?

Anastrozole inhibits the aromatase enzyme. Aromatase converts certain hormones, including androgens, into estrogen. By reducing this conversion, anastrozole lowers circulating estrogen levels, particularly in postmenopausal women.

This mechanism can be beneficial when breast-cancer growth is stimulated by estrogen. However, estrogen also has important roles in bones, joints, blood vessels, the nervous system and reproductive health. Lowering estrogen can therefore produce unwanted effects.

In hormone-sensitive breast cancer, reducing estrogen exposure may slow cancer-cell growth. An oncologist uses appointments, imaging and other assessments to determine whether treatment is working.

Estrogen helps maintain bone strength. Prolonged estrogen reduction can accelerate bone loss and increase fracture risk. A clinician may recommend bone-density testing, calcium and vitamin D assessment, weight-bearing exercise or bone-protective treatment when appropriate.

Anastrozole may also affect cholesterol and cardiovascular risk. People with heart disease, diabetes, high blood pressure or a history of stroke should discuss their risk profile with the prescribing team.

Potential Side Effects and Health Risks

Possible side effects include hot flashes, sweating, joint, muscle or bone pain, headache, tiredness, nausea, vomiting, diarrhea, appetite changes, sleep difficulties, mood changes, vaginal dryness, reduced sexual interest, hair thinning and weight changes.

Joint stiffness and musculoskeletal pain are common reasons some patients find aromatase-inhibitor treatment difficult. Patients should not stop treatment independently; an oncology team may recommend symptom management, a treatment adjustment or another hormonal option.

Anastrozole can decrease bone mineral density and increase the risk of osteoporosis and fractures. Report new or worsening bone pain, height loss, persistent back pain or a suspected fracture. Bone-health monitoring may be recommended during treatment.

Visual symptoms are a safety concern. Blurred or double vision, flashes of light, spots, reduced vision or unusual sensitivity to light should be reported immediately. Seek urgent help for chest pain, severe shortness of breath, sudden weakness, fainting, rapid heartbeat or stroke symptoms.

Rare but serious reactions may include liver injury or severe allergy. Contact a healthcare professional for yellowing skin or eyes, dark urine, severe upper-right abdominal pain, facial swelling, difficulty breathing, widespread rash or blistering skin lesions. Anastrozole is contraindicated in patients with known hypersensitivity to the drug or its ingredients.

Mood changes, anxiety, depression, irritability or sleep disturbance may occur. Seek immediate help for suicidal thoughts, psychosis or behaviour creating an imminent safety risk.

Who Should Avoid Arimidex?

Arimidex may be unsuitable or require special medical consideration for people who are pregnant, planning pregnancy or breastfeeding; have not reached menopause; have an allergy to anastrozole; have significant liver disease; have osteoporosis or a history of fractures; or have ischemic heart disease or substantial cardiovascular risk.

Patients should also discuss high cholesterol, uncontrolled blood pressure, tamoxifen, estrogen-containing medicines, hormone replacement therapy, fertility medicines, osteoporosis treatments, anticoagulants and all vitamins or herbal products.

Premenopausal women should not use Arimidex for breast-cancer treatment unless specifically directed by a specialist within an appropriate treatment protocol. Canadian product information states that anastrozole should not be taken by premenopausal women.

Do not assume that a non-prescription supplement is interaction-free. Do not purchase anastrozole from a source that does not require a prescription. Unauthorized medicines may be counterfeit, incorrectly stored or different from the labelled strength.